Kolon Tissuegene

IN THE PRESS

Press Releases

KOLON TISSUEGENE HIGHLIGHTS LONG-TERM SAFETY DATA AND POTENTIAL U.S. FDA PATHWAY FOR TG-C AT OARSI WORLD CONGRESS

April 29, 2025

·

4 min read

Press Releases

KOLON TISSUEGENE COMPLETES PATIENT DOSING IN TWO PIVOTAL US PHASE III CLINICAL TRIALS FOR TG-C

July 11, 2024

·

3 min read

Drug Development

KOLON TISSUEGENE RESUMES TG-C PHASE III STUDIES IN THE U.S.

December 28, 2021

·

3 min read

Drug Development

Kolon TissueGene To Expand Indications For TG-C

December 3, 2021

·

3 min read

Drug Development

Kolon Tissuegene Announces Plans To Resume US Phase III Clinical Trial For TG-C

April 13, 2020

·

3 min read

Drug Development

Kolon TissueGene Doses First Patient in US Phase III Clinical Trial

November 21, 2018

·

2 min read

Drug Development

Kolon TissueGene To Start US Phase III Clinical Trial For Invossa™

July 6, 2018

·

3 min read

Business

TissueGene Announces Company Name Change To Kolon TissueGene, Inc.

March 16, 2018

·

3 min read

JOBS